Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value

Table 2

A collection of significantly differentially expressed lncRNAs detected via microarray analysis in seven NPC patients.

Upregulated		Downregulated
lncRNA	log2 fold-change (M/T)	lncRNA	log2 fold-change (M/T)
CR620154	94.02	TUBA4B	1,364.72
LOC84740	92.86	AK128150	1,120.20
nc-HOXB9-206	87.55	RP11-79C6.2	303.82
RP4-800M22.4	67.25	EFCAB10	274.84
RP11-450H5.1	65.75	RP11-1C1.7	208.11
RP11-429H5.1	64.15	RP11-275I14.4	206.67
CTC-327F10.5	62.57	CR607309	197.51
AK096329	58.19	RP1-20N18.4	196.02
AC079780.3	55.47	lincRNA-CDHR3	195.01
AK129524	53.04	BC041885	141.04
AL359062	50.10	lincRNA-TSPAN8	137.80
RP11-95M15.1	46.94	BC050410	131.80
RP11-455B3.1	45.48	RP4-539M6.14	130.89
RP11-188P8.2	41.74	IGKV	125.27
AC097523.2	41.72	AC013264.2	122.93
nc-HOXA11-86	41.48	CES4	120.27
RP11-600P1.1	38.72	CLLU1	108.35
LOC283392	33.97	TUBBP5	108.01
AK096314	33.87	RP11-128M1.1	105.58
AC116917.2	33.61	RP4-666F24.3	100.17

NPC: nasopharyngeal carcinoma; M: metastatic NPC tissue; T: primary NPC tissue.
False discovery rate (FDR) < 0.1%, .